您的购物车当前为空
BI-1347 是一种有效的、选择性的 CDK8/cyclinC 抑制剂,IC50值为 1 nM,可抑制肿瘤生存。


为众多的药物研发团队赋能,
让新药发现更简单!
BI-1347 是一种有效的、选择性的 CDK8/cyclinC 抑制剂,IC50值为 1 nM,可抑制肿瘤生存。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 356 | In stock | |
| 5 mg | ¥ 828 | In stock | |
| 10 mg | ¥ 1,320 | In stock | |
| 25 mg | ¥ 2,270 | In stock | |
| 50 mg | ¥ 3,390 | In stock | |
| 100 mg | ¥ 4,900 | In stock | |
| 200 mg | ¥ 6,820 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 649 | In stock |
BI-1347 相关产品
| 产品描述 | BI-1347 is a potent, selective inhibitor of CDK8/cyclinC (IC50: 1 nM). It shows tumor growth inhibition in an in vivo xenograft model. |
| 靶点活性 | CDK8:1 nM (cell free) |
| 分子量 | 356.42 |
| 分子式 | C22H20N4O |
| CAS No. | 2163056-91-3 |
| Smiles | CN(C)C(=O)Cn1cc(cn1)-c1ccc(cc1)-c1cncc2ccccc12 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 120 mg/mL (336.68 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (11.22 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容